NYSE · Asset Management · USD

BlackRock Health Sciences Trust (BME) Stock Analysis

BlackRock Health Sciences Trust (BME) is a Asset Management stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

BME

$45.68

+$0.18 (+0.40%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BME with… →

BME Key Statistics

As of Oct 21, 2026

Trading

Open: $45.40
Previous Close: $45.50
Day's Range: 45.09–45.76
52-Week Range: 37.37–46.43
Volume: 31.02K
Beta: 0.60

Valuation

P/E Ratio: 5.49
EPS (ttm): 8.15

Financials (FY)

Revenue (FY): $77.54M+222.10%
Net Income (FY): $76.97M+228.16%
Profit margin: 1,371.16%
1-Year Return: +27.30%

Dividend and dates

Dividend: 7.18%
Ex-Dividend Date: October 15, 2026
Avg Volume: 42.83K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, BME closed at $45.68, +27.30% over 1 year.

In fiscal 2025, BME reported revenue of $77.54M.

BME Stock Return by Calendar Year

BlackRock Health Sciences Trust (BME) 10-year return: what $10,000 became

1 year: $10,000 $12,730; +27.30%
5 years: $10,000 $13,229; +32.29%
10 years: $10,000 $25,756; +157.56%

If you had invested $10,000 in BlackRock Health Sciences Trust (BME) 10 years ago, at the close on October 21, 2016, it would have been worth $25,756 at the close on October 21, 2026: +157.56% in total, +9.92% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−6.77%+24.04%+16.16%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	+16.16%
2025	+17.86%
2024	−0.08%
2023	−1.08%
2022	−4.62%
2021	+7.25%
2020	+18.64%
2019	+24.04%
2018	+6.38%
2017	+23.10%
2016 (partial year)	−6.77%

As of October 21, 2026.

BME Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$77.54M	$76.97M	99.3%
2024	$24.07M	$23.45M	97.4%
2023	$20.41M	$20.02M	98.1%
2022	−$25.97M	−$26.47M	101.9%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$77.54M	—	—	$76.97M	99.3%
2024	$24.07M	—	—	$23.45M	97.4%
2023	$20.41M	—	—	$20.02M	98.1%
2022	−$25.97M	—	—	−$26.47M	101.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BME Dividend History

’16’17’18’19’20’21’22’23’24’25’26*

$3.14+20.7% vs 2024

Dividends per share, 2025 · 12 payments

Year	Dividends per share	Payments	Change
2026*	$2.36	9	—
2025	$3.14	12	+20.7%
2024	$2.61	12	+1.9%
2023	$2.56	12	+0.0%

Year	Dividends per share	Payments	Change
2026 (partial year)	$2.36	9	—
2025	$3.14	12	+20.7%
2024	$2.61	12	+1.9%
2023	$2.56	12	+0.0%
2022	$2.56	12	+4.8%
2021	$2.44	12	+1.6%
2020	$2.40	12	+0.0%
2019	$2.40	12	+0.0%
2018	$2.40	12	+0.0%
2017	$2.40	12	+140.0%
2016	$1.00	2	—

Most recent payment: $0.26 per share, ex-dividend September 15, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

BME Valuation vs Asset Management Median

Median of 512 stocks

Metric	BME	Asset Management median	vs median
P/E	5.49	9.44	42% below
Profit margin	1,371.16%	74.97%	1,296.2 pts above

Medians across 512 Asset Management stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The record here covers BlackRock Health Sciences Trust, ticker BME. The company sits in the Financial Services sector, in the Asset Management industry.

Over the past 52 weeks the price has ranged from $37.37 to $46.43. The most recent close on file for BME is $45.68, dated October 21, 2026. That is +$0.18 (+0.40%) against the previous close. The latest close sits 22.24% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $77.54M. Against the prior fiscal year total of $24.07M, that is a change of +222.10%. Net income for the same year was $76.97M. That is +228.16% against the prior fiscal year. Profit margin runs at 1,371.16%. That is 1,296.2 percentage points above the Asset Management median of 74.97%. Earnings per share on a trailing basis come to 8.15.

Across the 4 fiscal years on file, revenue moves from −$25.97M in 2022 to $77.54M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

BME trades at a trailing price-to-earnings ratio of 5.49. That is 41.84% below the Asset Management median of 9.44. 512 Asset Management companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is +27.30%. Measured over 10 years, that is +9.92% a year compounded. Beta against the wider market is reported at 0.6. Daily returns over the trailing 10 years annualize to a volatility of 19.83%.

Growth & Income

BME pays a dividend yielding 7.18%. That is 1.7 percentage points below the Asset Management median yield of 8.91%. The ex-dividend date on file is October 15, 2026. Dividends are recorded for 11 calendar years; 2026 shows 9 payments totalling $2.36 a share. The year before, 2025, totalled $3.14 a share.

Across the complete calendar years on file, 2019 returned +24.04% and 2022 returned −4.62%. Of the 9 complete calendar years on file, 6 finished higher. So far in 2026 the total return is +16.16%.

Peer Comparison

BlackRock Health Sciences Trust (BME) operates in the Asset Management industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
BlackRock Health Sciences Trust	BME	—	5.5
BlackRock, Inc.	BLK	$184.31B	25.8
Blackstone Inc.	BX	$127.43B	23.9
Brookfield Corporation	BN	$83.74B	69.5

The Asset Management industry average P/E ratio is 9.4x. BlackRock Health Sciences Trust trades at a P/E of 5.5.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Asset Management Stocks

BLK

BlackRock, Inc.

$184.31B

Blackstone Inc.

$127.43B

Brookfield Corporation

$83.74B

KKR

KKR & Co. Inc.

$83.00B

BAM

Brookfield Asset Management Ltd.

$73.36B

APO

Apollo Global Management, Inc.

$65.96B

View all Asset Management stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.11T

JPM

JPMorgan Chase & Co.

$890.13B

Visa Inc.

$765.68B

Mastercard Incorporated

$545.42B

BAC

Bank of America Corporation

$358.24B

View all Financial Services stocks →

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Visit website →